Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-α production through activation of NF-κB

International Immunology

Volumn 13, Issue 11, 2001, Pages 1391-1404

  Yi, Ae Kyung ^a,b   Yoon, Jae Geun ^a,b   Hong, Soon Cheol ^c,d   Redford, Thomas W ^e   Krieg, Arthur M ^f,g,h  

^a LE BONHEUR CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WALTHER CANCER INSTITUTE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h PFIZER INC   (United States)

Author keywords

Cytokines; Endotoxin shock; Inflammatory mediators; Lipopolysaccharide; Monocytes macrophages; Transcription factors

Indexed keywords

BACTERIAL DNA; DNA; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOKINE; MUTANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL STRAIN; CONCENTRATION (PARAMETERS); CPG ISLAND; CYTOKINE PRODUCTION; DNA METHYLATION; DNA TRANSFECTION; GENE ACTIVITY; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; MEDIATOR; NONHUMAN; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0035163566     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.11.1391     Document Type: Article

References (64)

1. CpG motifs in bacterial DNA trigger direct B cell activation
2. CpG DNA: A novel immunomodulator
3. Mechanisms and therapeutic applications of immune stimulatory CpG DNA
4. Mechanism of Action of CpG DNA
5. Bacterial CpG DNA activates immune cells to signal infections danger
6. Bacterial DNA induces NK cells to produce interferon-gamma in vivo and increases the toxicity of lipopolysaccharides
7. Bacterial DNA causes septic shock
8. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis
9. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
10. IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides
11. L
12. Rapid immune activation by CpG motifs in bacterial DNA: Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway
13. Cyclosporine A enhances IL-12 production by CpG motifs in Oligodeoxynucleotides
14. CpG oligodeoxyribonucleotides rescue mature murine spleen B cells from spontaneous apoptosis and promote cell cycle entry
15. CpG DNA rescue from anti-IgM induced WEHI-231 B lymphoma apoptosis via modulation of IκBα and IκBβ and sustained activation of nuclear factor-κB/c-Rel
16. CpG DNA rescues B cells from apoptosis by activating NFκB and preventing mitochondrial membrane potential disruption via a chloroquine sensitive pathway
17. Rescue of B cells from apoptosis by immune stimulatory CpG DNA
18. IL-10 functions in vitro and in vivo to inhibit bacterial DNA-induced secretion of IL-12
19. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species
20. CpG DNA and LPS induce distinct patterns of activation in human monocytes
21. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
22. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
23. CpG DNA induces sustained IL-12 expression in vivo and resistance to L. monocytogenes challenge
24. h1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
25. h1 responses
26. Toll-like receptors in the induction of the innate immune response
27. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
28. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
29. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
30. A toll-like receptor recognizes bacterial DNA
31. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6
32. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA
33. CpG DNA specific activation of antigen presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
34. Rapid induction of mitogen activated protein kinases by immune stimulatory CpG DNA
35. Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells
36. Endotoxin, tumor necrosis factor, and related mediators: New approaches to shock
37. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes
38. A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines
39. Requirement for nuclear factor-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes
40. CTLA-4 ligation suppresses CD28-induced NF-κB and AP-1 activity in mouse T cell blasts
41. Characterization of a new isoform of the NF-AT (nuclear factor of activated T cells) gene family member NF-ATc
42. Recombination signal sequence binding protein Jκ is constitutively bound to the NF-κB site of the interleukin-6 promoter and acts as a negative regulatory factor
43. Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide
44. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four κB like motifs and of constitutive and inducible forms of NF-κB
45. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the Ras/Raf-1/MEK/MAPK pathway
46. Mechanisms and therapeutic applications of immune stimulatory CpG DNA
47. The role of CpG dinucleotides in DNA vaccines
48. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
49. Bacterial DNA and LPS act in synergy in inducing nitric oxide production in Raw 264.7 macrophages
50. Introduction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10
51. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphylococus aureus in human monocytes
52. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production
53. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways
54. Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-α through a post-transcriptional mechanism
55. Endotoxin-responsive sequences control cachectin/TNF biosynthesis at the translational level
56. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
57. Macrophages ingest and are activated by bacterial DNA
58. Positive and negative regulatory elements contribute to CpG oligonucleotide-mediated regulation of human IL-6 gene expression
59. Mechanism and function of a newly identified CpG DNA motif in human primary B cells
60. The regulation of the human tumor necrosis factor promoter region in macrophage, T cell, and B cell lines
61. Cloning and characterization of human TNF promoter region
62. Cell type specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NF-ATp and ATF-2/JUN
63. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: Role of NF-kappa B
64. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: Glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK